These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10458496)

  • 1. A case of interferon alpha-induced manic psychosis in chronic hepatitis C.
    Kanno A; Yamada M; Abe M; Okamoto Y
    Tohoku J Exp Med; 1999 Jan; 187(1):79-82. PubMed ID: 10458496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
    Schäfer M; Boetsch T; Laakmann G
    Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis associated with interferon alfa therapy for chronic hepatitis B.
    Tamam L; Yerdelen D; Ozpoyraz N
    Ann Pharmacother; 2003 Mar; 37(3):384-7. PubMed ID: 12639168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged psychosis associated with interferon therapy in a patient with hepatitis C: case study and literature review.
    Cheng YC; Chen CC; Ho AS; Chiu NY
    Psychosomatics; 2009; 50(5):538-42. PubMed ID: 19855041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
    Neri S; Pulvirenti D; Bertino G
    Clin Drug Investig; 2006; 26(11):655-62. PubMed ID: 17163300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.
    Dell'Osso L; Pini S; Maggi L; Rucci P; Del Debbio A; Carlini M; Baldini A; Ferrari G; Manca E; Beverini E; Amore M; Scarallo V; Semeraro Q; Brunetto M; Bonino F; Maj M
    J Psychosom Res; 2007 Mar; 62(3):349-55. PubMed ID: 17324686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression.
    Zincke MT; Kurani A; Istafanous R; Kellner C
    J ECT; 2007 Dec; 23(4):291-2. PubMed ID: 18090708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.
    Maddock C; Baita A; Orrù MG; Sitzia R; Costa A; Muntoni E; Farci MG; Carpiniello B; Pariante CM
    J Psychopharmacol; 2004 Mar; 18(1):41-6. PubMed ID: 15107183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing the neuropsychiatric complications of hepatitis C treatment.
    Sockalingam S; Shammi C; Stergiopoulos V
    Br J Hosp Med (Lond); 2007 Oct; 68(10):520-5. PubMed ID: 17974293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on the paper 'The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study'.
    Loftis JM; Hauser P
    Hum Psychopharmacol; 2005 Apr; 20(3):211-2; author reply 213. PubMed ID: 15799008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha].
    Drózdz W; Ziółkowska-Kochan M; Kozielewicz D; Dybowska D; Borkowska A; Halota W
    Przegl Epidemiol; 2008; 62(1):93-100. PubMed ID: 18536230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
    Raison CL; Demetrashvili M; Capuron L; Miller AH
    CNS Drugs; 2005; 19(2):105-23. PubMed ID: 15697325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and impact of manic traits in depressed patients initiating interferon therapy for chronic hepatitis C infection.
    Lim C; Olson J; Zaman A; Phelps J; Ingram KD
    J Clin Gastroenterol; 2010 Aug; 44(7):e141-6. PubMed ID: 20495465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
    Kim SR; Imoto S; Mita K; Taniguchi M; Sasase N; Muramatsu A; Kudo M; Kitai S; El-Shamy A; Hotta H; Hayashi Y
    Digestion; 2009; 79(1):36-9. PubMed ID: 19246919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
    Couzigou P; Pérusat S; Bourlière M; Trimoulet P; Poynard T; Leroy V; Marcellin P; Foucher J; Bronowicki JP; Chêne G;
    J Gastroenterol Hepatol; 2013 Feb; 28(2):329-34. PubMed ID: 23190183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of deep venous thrombosis associated with pegylated interferon alpha2b plus ribavirin treatment of chronic hepatitis C.
    Okuse C; Adachi K; Katakura Y; Matsunaga K; Ishii T; Matsumoto N; Yotsuyanagi H; Iino S; Suzuki M; Itoh F
    J Gastroenterol; 2006 Dec; 41(12):1231-6. PubMed ID: 17287904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.